- Capital Cube•15 hours ago
Categories: Yahoo Finance Misonix, Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 72. Our analysis is based on comparing Misonix, Inc. with the following peers – Stryker Corporation, Bovie Medical Corporation, Integra LifeSciences Holdings Corporation, Cesca Therapeutics Inc., Intuitive Surgical, Inc., Johnson & Johnson, Cynosure, Inc. Class A, Biostage, Inc., Medtronic plc and ... Read more (Read more...)
- Accesswire•17 hours agoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Misonix, Inc. and Encourages Investors with Losses to Contact the Firm
IRVINE, CA / ACCESSWIRE / October 26, 2016 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Misonix, Inc. ("Misonix" or the "Company") ...
- GlobeNewswire•18 hours agoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Misonix, Inc. - MSON
NEW YORK, Oct. 26, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Misonix, Inc. securities from November 5, 2015 through ...
Misonix, Inc. (MSON)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||5.75 x 25000|
|Day's Range||5.75 - 5.94|
|52wk Range||3.83 - 11.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||14.61|
|Avg Vol (3m)||16,507|
|Dividend & Yield||N/A (N/A)|